Soleno Therapeutics, Inc.SLNONASDAQ
Loading
Debt to Equity Over TimeCompressed
Percentile Rank69
3Y CAGR-26.4%
5Y CAGR+14.4%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
-26.4%/yr
Annual compound
5Y CAGR
+14.4%/yr
Recent deceleration
Percentile
P69
Within normal range
vs 5Y Ago
2x
Strong expansion
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.01 | -97.2% |
| 2024 | 0.22 | +8323.2% |
| 2023 | 0.00 | -82.9% |
| 2022 | 0.01 | -41.7% |
| 2021 | 0.03 | +741.6% |
| 2020 | 0.00 | -85.0% |
| 2019 | 0.02 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |